TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29074964

Group type: EXPERIMENTAL
Intervention: Participation in the ENCHANTED trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participation in the ENCHANTED trial (specifically in China)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participation in the ENCHANTED trial (other countries)
Number of subjects: 0
Study: 25698099

Group type: EXPERIMENTAL
Intervention: NUTRIC score
Number of subjects: 1199

Group type: EXPERIMENTAL
Intervention: Nutritional adequacy
Number of subjects: 1199
Study: 24902959

Group type: EXPERIMENTAL
Intervention: Community medicine distributors (CMDs)
Number of subjects: 752

Group type: COMPARATOR
Intervention: Health facilities
Number of subjects: 752
Study: 22991796

Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency (PRF) applied for 120 seconds after nerve root block (RB)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Nerve root block (RB) only
Number of subjects: 27

Group type: COMPARATOR
Intervention: Comparison between PRF and RB
Number of subjects: 27
Study: 19776408

Group type: EXPERIMENTAL
Intervention: Rasagiline 1 mg per day
Number of subjects: 1176

Group type: EXPERIMENTAL
Intervention: Rasagiline 2 mg per day
Number of subjects: 1176
Study: 17393324

Group type: EXPERIMENTAL
Intervention: ondansetron (8 mg bid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 15256191

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 302

Group type: COMPARATOR
Intervention: Carbamazepine
Number of subjects: 302

Group type: COMPARATOR
Intervention: Valproate
Number of subjects: 302
Study: 11254118

Group type: EXPERIMENTAL
Intervention: Combination drug therapies (including DTIC plus interferon-alpha)
Number of subjects: 3273

Group type: EXPERIMENTAL
Intervention: DTIC plus interferon-alpha
Number of subjects: 3273

Group type: EXPERIMENTAL
Intervention: DTIC-containing multi-drug regimens
Number of subjects: 3273

Group type: COMPARATOR
Intervention: Non-DTIC-containing treatment programmes
Number of subjects: 3273
Study: 9883438

Group type: EXPERIMENTAL
Intervention: Fibre-free alginate dressing (Comfeel SeaSorb)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Conventional treatment (paraffin-impregnated gauze, Jelonet)
Number of subjects: 17
Study: 7715293

Group type: EXPERIMENTAL
Intervention: Bengal-3
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: MO10
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: VRI-16
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Bengal-15
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Bengal-15 (10^8 CFU)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Buffer recipients
Number of subjects: 16

Group type: COMPARATOR
Intervention: Challenge with V cholerae O139
Number of subjects: 16
Study: 2619027

Group type: EXPERIMENTAL
Intervention: Controlled-release dihydrocodeine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Escape analgesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Antiemetic therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Significant nausea and vomiting
Number of subjects: 40
Study: 834966

Group type: EXPERIMENTAL
Intervention: Serum calcitonin levels during acute pancreatitis
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Normal Ct-values after 10 days of symptoms
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Serum calcium levels
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Calcitonin release in hyperparathyroidism
Number of subjects: 29
Study: 31776447

Group type: EXPERIMENTAL
Intervention: Higher polygenic risk score
Number of subjects: 7319

Group type: COMPARATOR
Intervention: Germline risk SNPs
Number of subjects: 7319
Study: 31220046

Group type: EXPERIMENTAL
Intervention: Recurrent Pneumococcal Meningitis (RPM) cases
Number of subjects: 24
Study: 28759396

Group type: EXPERIMENTAL
Intervention: 5-mL syringe for 2-mL dose
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: 10-mL syringe for 7.5-mL dose
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Milliliter/teaspoon labels and tools
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Text only instructions
Number of subjects: 491
Study: 25657355

Group type: EXPERIMENTAL
Intervention: 1-year extension of specialised early intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Step-down care
Number of subjects: 0
Study: 23880373

Group type: EXPERIMENTAL
Intervention: 2-back task trials
Number of subjects: 9

Group type: COMPARATOR
Intervention: 0-back task trials
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both tasks
Number of subjects: 9
Study: 21826680

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided antidromic sensory nerve conduction study (NCS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Previous technique (not specified)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technique
Number of subjects: 0
Study: 19851159

Group type: EXPERIMENTAL
Intervention: USG guided injection (triamcinolone 40 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: LMG guided injection (triamcinolone 40 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: USG guided injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: LMG guided injection
Number of subjects: 60
Study: 16720966

Group type: EXPERIMENTAL
Intervention: Function-centred treatment (FCT) group with Functional Capacity Evaluation (FCE) results available to physicians.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pain-centred treatment (PCT) group without FCE results available to physicians.
Number of subjects: 0
Study: 14707315

Group type: EXPERIMENTAL
Intervention: Ropinirole 0.25‐4.0 mg once daily
Number of subjects: 284

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Ropinirole
Number of subjects: 284
Study: 11583826

Group type: EXPERIMENTAL
Intervention: ACE-inhibitors and steroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Highly active anti-retroviral therapy
Number of subjects: 0
Study: 9207158

Group type: EXPERIMENTAL
Intervention: Fibrin sealant with standard cauterization
Number of subjects: 149

Group type: COMPARATOR
Intervention: Cauterization alone (Control)
Number of subjects: 149
Study: 8488128

Group type: EXPERIMENTAL
Intervention: Oligoantigenic regimen (including 8 simple foods) for 4 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: No diet nor pharmacological prophylaxis (Control group B)
Number of subjects: 43
Study: 6360111

Group type: EXPERIMENTAL
Intervention: Orthokeratology treatment group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 31668907

Group type: EXPERIMENTAL
Intervention: Cricothyroid Visor Maneuver (CVM)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Manual Circumlaryngeal Therapy (MCT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control Group (no treatment)
Number of subjects: 88
Study: 30340794

Group type: EXPERIMENTAL
Intervention: 16 week exercise intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study: 30030480

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 88
Study: 27082620

Group type: EXPERIMENTAL
Intervention: Dorsal penile nerve block (DPNB) with 15 mL of 0.33% ropivacaine
Number of subjects: 58

Group type: COMPARATOR
Intervention: Intravenous tramadol 1.5 mg/kg
Number of subjects: 58
Study: 23665883

Group type: EXPERIMENTAL
Intervention: Dexketoprofen trometamol
Number of subjects: 52

Group type: COMPARATOR
Intervention: Meperidine HCl
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study: 22221319

Group type: EXPERIMENTAL
Intervention: 5-week dietary intervention containing several anti-inflammatory ingredients
Number of subjects: 36
Study: 19712211

Group type: EXPERIMENTAL
Intervention: Search filters for retrieving RCTs from medline
Number of subjects: 161
Study: 17237729

Group type: EXPERIMENTAL
Intervention: Neutral temperature (NT)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Comfort temperature (CT)
Number of subjects: 2
Study: 16948810

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection before pneumatic dilatation
Number of subjects: 54

Group type: COMPARATOR
Intervention: Pneumatic dilatation alone
Number of subjects: 54
Study: 15205229

Group type: EXPERIMENTAL
Intervention: FC latanoprost/timolol
Number of subjects: 325

Group type: COMPARATOR
Intervention: UFC brimonidine/timolol
Number of subjects: 325
Study: 10816401

Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 60

Group type: COMPARATOR
Intervention: Plain abdominal radiography (AXR)
Number of subjects: 60
Study: 8669519

Group type: EXPERIMENTAL
Intervention: Social-behavioral curricula in schools, peer leadership, parental involvement/education, and communitywide task force activities (implemented for 3 school years from 1991 to 1994)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference districts (control group)
Number of subjects: 0
Study: 1775253

Group type: EXPERIMENTAL
Intervention: High and low sodium dialysate (HLSD)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Standard haemodialysis (HD)
Number of subjects: 6
Study: 6828829

Group type: EXPERIMENTAL
Intervention: Ultrasound treatment (1 Watt/cm2)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Ultrasound treatment in lidocaine blocked fibromyotic muscle
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Ultrasound treatment in normal lidocaine pretreated muscle
Number of subjects: 7
Study: 31964381

Group type: EXPERIMENTAL
Intervention: Intrafractional vaginal dilation using a tampon of a specific diameter during treatment.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard (chemo) radiation with a total dose of 45-50.4 Gy to the pelvic and inguinal nodes with a boost to the anal canal up to 54-60 Gy.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Daily use of a tampon during treatment.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Use of a vaginal dilator.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Quality of life assessment.
Number of subjects: 60
Study: 30862274

Group type: EXPERIMENTAL
Intervention: Seated TSTM
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Supine TSTM
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 60
Study: 28930830

Group type: EXPERIMENTAL
Intervention: 20 mL 0.3% ropivacaine plus 2 mL 1.0 μg/kg dexmedetomidine (group DR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 20 mL 0.3% ropivacaine plus 2 mL normal saline (group R)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (group R and group DR)
Number of subjects: 50
Study: 25755255

Group type: EXPERIMENTAL
Intervention: Proton beam therapy (PBT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: X-ray chemoradiotherapy
Number of subjects: 44
Study: 24016546

Group type: EXPERIMENTAL
Intervention: SICTRA (saline‐irrigated cooled tip radiofrequency ablation)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Catheter ablation
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Repeated catheter ablation
Number of subjects: 95
Study: 21295635

Group type: EXPERIMENTAL
Intervention: Artificial Neural Network (ANN) - TWIST system, Semeion
Number of subjects: 2380
Study: 18704555

Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 16764215

Group type: EXPERIMENTAL
Intervention: Buprenorphine (0.7-9 microg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fentanyl (17 microg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naloxone (to reverse buprenorphine-induced respiratory depression)
Number of subjects: 0
Study: 15233393

Group type: EXPERIMENTAL
Intervention: Rearfoot-forefoot posted orthosis
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High medial longitudinal arch with extrinsic rearfoot post
Number of subjects: 18

Group type: COMPARATOR
Intervention: No orthosis
Number of subjects: 18
Study: 11006919

Group type: EXPERIMENTAL
Intervention: 50 g of extra virgin olive oil per day
Number of subjects: 22

Group type: COMPARATOR
Intervention: 50 g of refined olive oil with no simple phenols
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 100 g of extra virgin olive oil (Postprandial trial)
Number of subjects: 22
Study: 9351616

Group type: EXPERIMENTAL
Intervention: 0.5 microg LPS
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 5 microg LPS
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 50 microg LPS
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 9
Study: 8404558

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 50
Study: 2938520

Group type: COMPARATOR
Intervention: Alfentanil alone (93 +/- 6 micrograms/kg)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Midazolam (50 and 100 micrograms/kg) prior to alfentanil
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Midazolam-alfentanil combination
Number of subjects: 27
Study: 31425349

Group type: EXPERIMENTAL
Intervention: Body weight-supported overground walking training combined with conventional physiotherapy for 4 weeks
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional physiotherapy alone
Number of subjects: 37
Study: 28188369

Group type: EXPERIMENTAL
Intervention: Self-stigma at baseline
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Increase of self-stigma from baseline to follow-up
Number of subjects: 222
Study: 27020439

Group type: EXPERIMENTAL
Intervention: Uninterrupted use of novel oral anticoagulants (NOACs) (group I, n = 64)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Interrupted use of NOACs (group II, n = 42)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Continuation of vitamin K antagonist (VKA) with INR between 2.0 and 3.0 (group III, n = 43)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: VKA discontinuation bridged with low molecular weight heparin (group IV, n = 43)
Number of subjects: 192
Study: 25190056

Group type: EXPERIMENTAL
Intervention: Imara intervention (three individual sessions and four phone sessions)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control group (usual care: STI testing, treatment, and counseling)
Number of subjects: 188
Study: 23158779

Group type: EXPERIMENTAL
Intervention: Serum anticholinergic activity (SAA)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Lower gray matter volume in the left DLPFC
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: SAA
Number of subjects: 47
Study: 21036834

Group type: EXPERIMENTAL
Intervention: Amphotericin B with 500 mL of physiologic saline and 30 mL (60 meq/L) of KCl
Number of subjects: 230

Group type: COMPARATOR
Intervention: Amphotericin B only (1 mg/kg/day for 20 days)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Both groups (test and control)
Number of subjects: 230
Study: 18834340

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol 100 microg
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol 200 microg
Number of subjects: 300

Group type: COMPARATOR
Intervention: i.v. methylergometrine 200 microg
Number of subjects: 300
Study: 16086715

Group type: EXPERIMENTAL
Intervention: Budesonide 6 mg
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Budesonide 3 mg
Number of subjects: 380

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 380
Study: 11387857

Group type: EXPERIMENTAL
Intervention: Biofeedback‐assisted relaxation training (10 sessions of weekly training)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 0
Study: 9702851

Group type: EXPERIMENTAL
Intervention: Eprosartan 300 mg twice a day for 7 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo twice a day for 7 days
Number of subjects: 18
Study: 8017472

Group type: EXPERIMENTAL
Intervention: Fluvastatin (40 mg single dose)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 18
Study: 2574906

Group type: EXPERIMENTAL
Intervention: Maintenance therapy with H2-receptor antagonists
Number of subjects: 140

Group type: COMPARATOR
Intervention: No maintenance therapy
Number of subjects: 140
Study: 1165130

Group type: EXPERIMENTAL
Intervention: Sodium ethacrynate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prostaglandin A1 (PGA1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31132182

Group type: EXPERIMENTAL
Intervention: Crisaborole ointment, applied twice daily for 28 days.
Number of subjects: 1522

Group type: COMPARATOR
Intervention: Vehicle (control group), applied twice daily for 28 days.
Number of subjects: 1522
Study: 29295296

Group type: EXPERIMENTAL
Intervention: SMS messages
Number of subjects: 73
Study: 26003642

Group type: EXPERIMENTAL
Intervention: Xuebijing injection (100 mL once a day for 7 days)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Xuebijing injection
Number of subjects: 62
Study: 22289020

Group type: EXPERIMENTAL
Intervention: R2 diet (50% concentrate mixture and 50% tree foliages)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: R3 diet (50% concentrate mixture and 50% rice straw)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: R4 diet (50% concentrate mixture, 25% tree foliages, and 25% rice straw)
Number of subjects: 20

Group type: COMPARATOR
Intervention: R1 diet (tree foliages only)
Number of subjects: 20
Study: 21304148

Group type: EXPERIMENTAL
Intervention: Fentanyl buccal tablet (FBT)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Immediate-release oxycodone
Number of subjects: 323
Study: 19298620

Group type: EXPERIMENTAL
Intervention: Participation in a proposed emergency treatment trial for SAH
Number of subjects: 905

Group type: EXPERIMENTAL
Intervention: Demographic characteristics (age, sex, race/ethnicity, education, religion, clinical setting, reason for visit, history of neurologic injury)
Number of subjects: 905

Group type: EXPERIMENTAL
Intervention: Identification of family member as proxy decision-maker
Number of subjects: 905
Study: 16520413

Group type: EXPERIMENTAL
Intervention: Intracoronary bone marrow cell (BMC) transfer
Number of subjects: 60

Group type: COMPARATOR
Intervention: Optimal postinfarction therapy (Control)
Number of subjects: 60
Study: 15248624

Group type: EXPERIMENTAL
Intervention: Microcuff endotracheal tube
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional endotracheal tubes (Mallinckrodt HiLo, Portex Profile Soft Seal, Rüsch Super Safety Clear, Sheridan CF)
Number of subjects: 50
Study: 10950800

Group type: EXPERIMENTAL
Intervention: Filgrastim 300 microg/day
Number of subjects: 480

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study: 8644584

Group type: EXPERIMENTAL
Intervention: Flexible sheath
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonflexible sheath
Number of subjects: 60
Study: 1630805

Group type: EXPERIMENTAL
Intervention: Interferon treatment for chronic type B hepatitis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interferon treatment for chronic type C hepatitis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interferon treatment for hepatitis Delta infection
Number of subjects: 0
Study: 6368141

Group type: EXPERIMENTAL
Intervention: Fenoterol 0.4 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fenoterol 0.8 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31900843

Group type: EXPERIMENTAL
Intervention: Montelukast sodium plus budesonide
Number of subjects: 180

Group type: COMPARATOR
Intervention: Budesonide (control group)
Number of subjects: 180
Study: 29136096

Group type: EXPERIMENTAL
Intervention: Optimized design (larger and red)
Number of subjects: 646

Group type: COMPARATOR
Intervention: Current in market alcohol warning label
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: Self-reported attention for optimized design
Number of subjects: 646
Study: 26139005

Group type: EXPERIMENTAL
Intervention: CZP+MTX
Number of subjects: 316
Study: 26425812

Group type: EXPERIMENTAL
Intervention: Short implants (6 mm)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Long implants (11-15 mm) with sinus grafting
Number of subjects: 97
Study: 23833852

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.165% with fentanyl 2.0 micro g/ml
Number of subjects: 70

Group type: COMPARATOR
Intervention: Levobupivacaine 0.125% with fentanyl 2.0 micro g/ml
Number of subjects: 70
Study: 21092287

Group type: EXPERIMENTAL
Intervention: PEG‐IFN alpha‐2b (40‐kDa), single 180 micrograms dose, subcutaneously administered
Number of subjects: 16

Group type: COMPARATOR
Intervention: PEG‐IFN alpha‐2a (reference), single 180 micrograms dose, subcutaneously administered
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 16
Study: 18206917

Group type: EXPERIMENTAL
Intervention: Burch colposuspension
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: Autologous rectus sling
Number of subjects: 655

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 655
Study: 16628153

Group type: EXPERIMENTAL
Intervention: Blink reflex (BR) evaluation in diabetic patients with PN
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Correlation analysis of R1, IR2, and CR2 latencies
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Routine nerve conduction studies
Number of subjects: 188
Study: 12884193

Group type: EXPERIMENTAL
Intervention: Celsior solution (CS)
Number of subjects: 173

Group type: COMPARATOR
Intervention: University of Wisconsin solution (UW)
Number of subjects: 173
Study: 10640263

Group type: EXPERIMENTAL
Intervention: pivampicillin plus pivmecillinam (40 mg/kg/day and 50 mg/kg/day respectively)
Number of subjects: 56

Group type: COMPARATOR
Intervention: pivampicillin (50 mg/kg/day)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: pivampicillin plus pivmecillinam
Number of subjects: 56

Group type: COMPARATOR
Intervention: pivampicillin
Number of subjects: 56
Study: 8881083

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observational studies
Number of subjects: 0
Study: 2060415

Group type: EXPERIMENTAL
Intervention: Telematic transmission of computerized SMBG
Number of subjects: 22

Group type: COMPARATOR
Intervention: Traditional booklets for SMBG
Number of subjects: 22
Study: 6230883

Group type: EXPERIMENTAL
Intervention: Zimeldine
Number of subjects: 263

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 263

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263